Ligand Pharmaceuticals reports Q1 2026 earnings via press release
Filed May 7, 2026 · Period ending May 7, 2026 · ~1 min read
Key Changes
-
high
Company announced financial results for the three months ended March 31, 2026, through a press release furnished as an exhibit to this 8-K filing.
Item 2.02 verify on EDGAR → -
medium
The 8-K filing itself contains no financial figures or performance metrics; actual results are disclosed only in the attached press release (Exhibit 99.1).
8-K: Exhibits verify on EDGAR →
This preview is just the start — the full report includes the narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.
Want to see a complete report first? Today's free report (SMID 10-Q) is open in full — no account needed.
Partner
Trade LGNYZ commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Generated by AI · Jun 10, 2026 11:08 PM